<DOC>
	<DOCNO>NCT02185118</DOCNO>
	<brief_summary>Sepsis major cause death intensive care unit . Despite investigator improve understanding , reduce risk die sepsis , number people die year continue increase due overall increase number cases.In previous study , investigator show 100 % oxygen 0.5 minimum alveolar concentration ( MAC ) isoflurane/sevoflurane 60 % oxygen protect mouse macrophage cell line in-vitro sepsis induce lipopolysaccharide ( LPS ) . In study , investigator hypothesize treatment 100 % oxygen 0.5 MAC isoflurane/sevoflurane 60 % oxygen protect clinical in-vitro model sepsis induce LPS plasma septic patient .</brief_summary>
	<brief_title>Effects Subanesthetic Isoflurane/Sevoflurane 60 % Oxygen Clinical In-vitro Experimental Sepsis</brief_title>
	<detailed_description>100 % oxygen 0.5 MAC isoflurane/sevoflurane 60 % oxygen would inhibit increase tumor necrosis factor ( TNF ) -alpha , interleukin-1beta , interleukin-6 cell culture supernatant stimulation LPS plasma septic patient , also inhibit nuclear location nuclear factor-kappa B p65 subunit .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Human PBMCs isolate adult patient without sepsis/SIRS/infectious disease . The plasma induction clinical invitro sepsis , isolated adult patient sepsis . Patients select clinical trial 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>